ImmunoPrecise Antibodies Ltd IPA
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if IPA is a good fit for your portfolio.
News
-
ImmunoPrecise Antibodies to Reschedule Financial Results and Recent Business Highlights Report for Fourth Quarter and Fiscal Year-End 2024
-
ImmunoPrecise Announces Financing Agreement with Yorkville Advisors Global, LP of up to $3.0 Million Aggregate Principal Amount of Convertible Debentures
-
IPA to Report Financial Results and Recent Business Highlights for Fourth Quarter and Fiscal Year End 2024 on July 25th, 2024
-
ImmunoPrecise Appoints Kristin Taylor as Chief Financial Officer
-
IPA’s Subsidiary BioStrand and PGxAI Announce Strategic Collaboration to Develop First-In-Class AI Model for Pharmacogenomics Recommendations Using LENSai™
-
ImmunoPrecise Antibodies Ltd. Subsidiary BioStrand Receives Prestigious 2024 Impact Award for Groundbreaking LENSai™ Technology
-
BioStrand, ImmunoPrecise Antibodies’ Subsidiary, Announces Immediate Commercial Offering of Groundbreaking Software with Customizable Interface for AI-Driven Drug Discovery
-
IPA’s Subsidiary, BioStrand, Announces Advanced Large Language Model (LLM) for Electronic Health Records (EHR)
Trading Information
- Previous Close Price
- $0.83
- Day Range
- $0.80–0.86
- 52-Week Range
- $0.80–2.73
- Bid/Ask
- $0.82 / $1.00
- Market Cap
- $22.63 Mil
- Volume/Avg
- 85,480 / 75,140
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1.24
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
ImmunoPrecise Antibodies Ltd is a supplier of custom antibodies to the research industry and industrial community. The company has aggregated its operations into one reportable segment, Antibody Production, and Related Services. It operates in three principal geographical areas - the United States of America, Canada, Europe, and others. The majority of its revenue is derived from Europe.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 102
- Website
- https://www.immunoprecise.com
Comparables
Valuation
|
Metric
|
IPA
|
NYKD
|
IBRX
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | — |
Price/Book Value | 0.61 | 2.79 | — |
Price/Sales | 1.24 | 40.25 | — |
Price/Cash Flow | — | — | — |
Price/Earnings
IPA
NYKD
IBRX
Financial Strength
|
Metric
|
IPA
|
NYKD
|
IBRX
|
|---|---|---|---|
Quick Ratio | 1.18 | 8.43 | 3.21 |
Current Ratio | 1.66 | 8.43 | 3.64 |
Interest Coverage | −387.88 | — | −3.40 |
Quick Ratio
IPA
NYKD
IBRX
Profitability
|
Metric
|
IPA
|
NYKD
|
IBRX
|
|---|---|---|---|
Return on Assets (Normalized) | −15.85% | −18.26% | −119.98% |
Return on Equity (Normalized) | −22.58% | −23.64% | — |
Return on Invested Capital (Normalized) | −19.91% | −26.98% | −188.07% |
Return on Assets
IPA
NYKD
IBRX
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Novo Nordisk A/S ADR
NVO
| Nlyzpntwnq | Jfbt | $565.6 Bil | |||
| Vertex Pharmaceuticals Inc
VRTX
| Ymsgtdvz | Ybnkcg | $127.8 Bil | |||
| Regeneron Pharmaceuticals Inc
REGN
| Vycxjtzf | Xswfy | $118.7 Bil | |||
| Moderna Inc
MRNA
| Sqplqlrxw | Ctb | $46.8 Bil | |||
| Alnylam Pharmaceuticals Inc
ALNY
| Qkkqlyjp | Crkdfr | $29.7 Bil | |||
| argenx SE ADR
ARGX
| Dbxzmqg | Dsm | $29.3 Bil | |||
| BioNTech SE ADR
BNTX
| Dnlccrhms | Qjsr | $20.7 Bil | |||
| Biomarin Pharmaceutical Inc
BMRN
| Vnjvykn | Trgbjzx | $16.1 Bil | |||
| United Therapeutics Corp
UTHR
| Jrmbnxpgp | Skjj | $15.0 Bil | |||
| Incyte Corp
INCY
| Gtghhwp | Bhlkdnk | $13.5 Bil |